Glucocorticoid steroids improved muscle performance through distinct, sex-specific mechanisms, according to a Northwestern Medicine study.
Browsing: Clinical Breakthroughs
Patients with COVID-19-associated lung disease who received lung transplants had similar outcomes compared to patients without COVID-19, according to a study published in JAMA.
Intensive treatment for patients with Crohn’s disease showed no safety differences compared to the current standard of care.
Patients receiving radiotherapy to treat high-risk prostate cancer benefit from androgen deprivation therapy, and length of treatment may be dependent on radiation deliver, according to a recent study.
The drug darolutamid, administered with standard androgen-deprivation therapy and docetaxel chemotherapy, increased survival in patients with metastatic hormone-sensitive prostate cancer.
Associate vice president of research Richard D’Aquila, MD, shares his perspective on the news of a possible third person cured of HIV, and the progress of HIV research in the future.
A new combination of antiviral drugs did not improve clinical outcomes in hospitalized patients with severe influenza, warranting further investigation into new therapeutic strategies, according to a recent clinical trial.
Treating breast tumors alongside distant metastases did not improve outcomes in women with stage IV breast cancer, according to a new study.
A novel combination treatment approach extended survival in mice with pancreatic cancer, demonstrating a potential second-line therapy for patients.
Sequencing known cardiac arrythmia genes in more than 20,000 people without an indication for genetic testing identified pathogenic variants in nearly one percent of individuals.